These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17697502)
1. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Old RW; Crea F; Puszyk W; Hultén MA Reprod Biomed Online; 2007 Aug; 15(2):227-35. PubMed ID: 17697502 [TBL] [Abstract][Full Text] [Related]
2. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma. Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362 [TBL] [Abstract][Full Text] [Related]
3. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156 [TBL] [Abstract][Full Text] [Related]
4. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Papageorgiou EA; Fiegler H; Rakyan V; Beck S; Hulten M; Lamnissou K; Carter NP; Patsalis PC Am J Pathol; 2009 May; 174(5):1609-18. PubMed ID: 19349366 [TBL] [Abstract][Full Text] [Related]
5. Hypomethylated DSCR4 is a placenta-derived epigenetic marker for trisomy 21. Du Y; Zhang J; Wang H; Yan X; Yang Y; Yang L; Luo X; Chen Y; Duan T; Ma D Prenat Diagn; 2011 Feb; 31(2):207-14. PubMed ID: 21268042 [TBL] [Abstract][Full Text] [Related]
6. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21. Lee DE; Lim JH; Kim MH; Park SY; Ryu HM J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512 [TBL] [Abstract][Full Text] [Related]
7. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma. Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853 [TBL] [Abstract][Full Text] [Related]
8. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing. Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811 [TBL] [Abstract][Full Text] [Related]
9. Noncoding RNA and DNA as biomarkers: toward an epigenetic fetal barcode for use in maternal plasma. Oudejans CB Clin Chem; 2008 Mar; 54(3):456-7. PubMed ID: 18310143 [No Abstract] [Full Text] [Related]
10. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Tong YK; Jin S; Chiu RW; Ding C; Chan KC; Leung TY; Yu L; Lau TK; Lo YM Clin Chem; 2010 Jan; 56(1):90-8. PubMed ID: 19850629 [TBL] [Abstract][Full Text] [Related]
11. Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis. Hatt L; Aagaard MM; Graakjaer J; Bach C; Sommer S; Agerholm IE; Kølvraa S; Bojesen A PLoS One; 2015; 10(7):e0128918. PubMed ID: 26230497 [TBL] [Abstract][Full Text] [Related]
12. Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Bunce K; Chu T; Surti U; Hogge WA; Peters DG Prenat Diagn; 2012 Jun; 32(6):542-9. PubMed ID: 22495992 [TBL] [Abstract][Full Text] [Related]
13. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions. Keravnou A; Ioannides M; Tsangaras K; Loizides C; Hadjidaniel MD; Papageorgiou EA; Kyriakou S; Antoniou P; Mina P; Achilleos A; Neofytou M; Kypri E; Sismani C; Koumbaris G; Patsalis PC Genet Res (Camb); 2016 Nov; 98():e15. PubMed ID: 27834155 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylated ERG as a cell-free fetal DNA biomarker for non-invasive prenatal testing of Down syndrome. Chen X; Xiong L; Zeng T; Xiao K; Huang Y; Guo H; Ren J Clin Chim Acta; 2015 Apr; 444():289-92. PubMed ID: 25749407 [TBL] [Abstract][Full Text] [Related]
15. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Chu T; Burke B; Bunce K; Surti U; Allen Hogge W; Peters DG Prenat Diagn; 2009 Nov; 29(11):1020-30. PubMed ID: 19650061 [TBL] [Abstract][Full Text] [Related]
16. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome. Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102 [TBL] [Abstract][Full Text] [Related]
17. DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing. Xiang Y; Zhang J; Li Q; Zhou X; Wang T; Xu M; Xia S; Xing Q; Wang L; He L; Zhao X Mol Hum Reprod; 2014 Sep; 20(9):875-84. PubMed ID: 24996894 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Lun FM; Chiu RW; Sun K; Leung TY; Jiang P; Chan KC; Sun H; Lo YM Clin Chem; 2013 Nov; 59(11):1583-94. PubMed ID: 23857673 [TBL] [Abstract][Full Text] [Related]
19. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21. Lim JH; Lee DE; Park SY; Kim DJ; Ahn HK; Han YJ; Kim MY; Ryu HM BMC Med Genomics; 2014 Jan; 7():1. PubMed ID: 24397966 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]